Monday, March 30, 2009

Pathway Medical Gains $40M

Kirkland, Washington-based Pathway Medical Technologies announced this morning that the firm has raised $40M in a Series D funding round. According to the firm, the funding came from Forbion Capital Partners, HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, Giza Venture Capital and individual investors. Pathway is developing treaments for peripheral arterial disease (PAD). Pathway said the new funding will go to build its sales team, manufacturing organizations, and for product development. The new funding brings the company's total raised to nearly $100M. More information »